
Am J Psychiatry 163:1542-1548, September 2006
doi: 10.1176/appi.ajp.163.9.1542
© 2006 American Psychiatric Association
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
Patrick J. McGrath, M.D.,
Jonathan W. Stewart, M.D.,
Frederic M. Quitkin, M.D.,
Ying Chen, M.D., M.S.,
Jonathan E. Alpert, M.D., Ph.D.,
Andrew A. Nierenberg, M.D.,
Maurizio Fava, M.D.,
Jianfeng Cheng, M.D., Ph.D., and
Eva Petkova, Ph.D.
OBJECTIVE: Loss of response to a previously effective antidepressant is a common clinical problem. Retrospective analyses have shown that the pattern of response during antidepressant treatment (late onset and persistent versus other patterns) can be used to predict relapse during continuation and maintenance treatment and possibly to identify placebo responses to treatment. This study was designed to test the predictive value of response pattern prospectively and to examine the data for other predictors of relapse. METHOD: Five hundred seventy persons with major depressive disorder were treated with fluoxetine for 12 weeks and their pattern of response was determined. Those who responded (N=292) underwent random assignment, under double-blind conditions, to continue taking fluoxetine or to switch to placebo for 52 weeks or until relapse. Survival analysis was used to examine the effect of covariates on relapse. RESULTS: Although fluoxetine was significantly more effective than placebo during maintenance treatment, this chronically ill group had a high rate of relapse. Contrary to previous findings, a pattern of acute response was not predictive of relapse. Chronicity, symptom severity, a neurovegetative symptom pattern, and female gender were all associated with a significantly greater risk of relapse, with no difference observed between fluoxetine and placebo. CONCLUSIONS: The pattern of response to acute treatment appears to be inconsistently predictive of relapse. There is a high rate of relapse with both active medication and placebo in patients with chronic depression. Illness characteristics predict loss of response both to fluoxetine and to placebo. No variable examined was predictive of differential relapse rates between fluoxetine and placebo.
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Arranz and S. Kapur
Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
Schizophr Bull,
August 27, 2008;
(2008)
sbn114v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Klein
The Loss of Serendipity in Psychopharmacology
JAMA,
March 5, 2008;
299(9):
1063 - 1065.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Bibliography for Major Depressive Disorder and Suicide
Focus,
January 1, 2008;
6(1):
58 - 62.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Frank, D. J. Kupfer, D. J. Buysse, H. A. Swartz, P. A. Pilkonis, P. R. Houck, P. Rucci, D. M. Novick, V. J. Grochocinski, and D. M. Stapf
Randomized Trial of Weekly, Twice-Monthly, and Monthly Interpersonal Psychotherapy as Maintenance Treatment for Women With Recurrent Depression
Focus,
January 1, 2008;
6(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Frank, D. J. Kupfer, D. J. Buysse, H. A. Swartz, P. A. Pilkonis, P. R. Houck, P. Rucci, D. M. Novick, V. J. Grochocinski, and D. M. Stapf
Randomized Trial of Weekly, Twice-Monthly, and Monthly Interpersonal Psychotherapy as Maintenance Treatment for Women With Recurrent Depression
Am J Psychiatry,
May 1, 2007;
164(5):
761 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Which Patients with Major Depression Will Relapse Despite Maintenance Fluoxetine?
Journal Watch Psychiatry,
October 16, 2006;
2006(1016):
4 - 4.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|